Senior insider sale
Chief Medical Officer at ADAPTIMMUNE THERAPEUTICS PLC — senior position signals high conviction
$16.2K
27.78K shares
What this filing means
NORRY ELLIOT plans to sell 27.78K shares of ADAPTIMMUNE THERAPEUTICS PLC valued at approximately $16.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/17/2025ACC: 0001970051-25-000009
Officer· Chief Medical Officer
Since Jan 2020
27.78K
Shares to sell
$16.2K
Approx. market value
5.58K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Sell to cover exercise (cashless)
COMPENSATION
1/17/2025
5.58KTotal acquired5.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2025 | Sell to cover exercise (cashless) COMPENSATION | 5.58K | — |
| Total | 5.58K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
9.80K
Market value
$5.6K
1/15/2025
—Completed
Units to sell
12.39K
Market value
$7.3K
1/13/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.58K
Market value
$3.2K
1/17/2025
Total
Units
27.78K
Value
$16.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/15/2025 | 9.80K | $5.6K | — | Completed |
1/13/2025 | 12.39K | $7.3K | — | Completed |
| Planned — Approximate Date | ||||
1/17/2025 | 5.58K | $3.2K | NASDAQ | Planned |
| Total | 27.78K | $16.2K | ||